LB19. Progress Toward a Vaccine for Maternal Immunization to Prevent Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Illness (LRTI) in Infants

BACKGROUND: RSV is the leading cause of infant LRTI and hospitalization worldwide. The greatest burden of severe disease is in term infants <5 months old. Novavax is developing an aluminum-adjuvanted RSV F nanoparticle vaccine for use in the third trimester of pregnancy, with the goal of preventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fries, Louis, Thomas, D Nigel, Smith, Gale, Plested, Joyce, Piedra, Pedro, Patel, Nita, Cho, Iksung, Glenn, Greg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254636/
http://dx.doi.org/10.1093/ofid/ofy229.2193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254636/
http://dx.doi.org/10.1093/ofid/ofy229.2193

Ejemplares similares